Business

PTC Therapeutics' 2023 STRIVE Awards Program Funds Initiatives Supporting the Duchenne Patient Community

- 2023 recipients include patient advocacy organizations in Australia and Brazil - SOUTH PLAINFIELD, N.J., Sept. 7, 2023 /PRNewswire/ -- PTC Therapeutics,

articlePtc Therapeutics, Inc.September 7, 20234/company/ptc-therapeutics-inc/news/ptc-therapeutics-2023-strive-awards-program-funds-initiatives-supporting-the-duchenne
PTC Therapeutics' 2023 STRIVE Awards Program Funds Initiatives Supporting the Duchenne Patient Community

About this update from Ptc Therapeutics, Inc.

[{"type":"text","content":"- 2023 recipients include patient advocacy organizations in Australia and Brazil -\nSOUTH PLAINFIELD, N.J., Sept. 7, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the two recipients of its 2023 STRIVE Awards for Duchenne Muscular Dystrophy. Through the STRIVE program, the company awards grants to non-profit patient advocacy organizations serving the Duchenne community. This year's grants will fund projects focused on developing a digital health app to support patients transitioning to adulthood in Australia and the expansion of a power soccer (also known as powerchair football) program in Brazil.\n\"The 2023 STRIVE grant recipients have demonstrated a strong commitment to their local Duchenne communities. We are excited by the additional support they will be able to provide patients and their families through this grant funding,\" said Mary Frances Harmon, senior vice president, Corporate Relations, PTC Therapeutics. \"As we near a decade of the STRIVE Awards program, we are proud to continue to provide organizations with support to expand their services for the Duchenne community.\"\nThere are two categories for the 2023 STRIVE Awards: Innovative and Transition to Adulthood. Innovative programs are those that help address the unmet needs of the rare disease community, Transition to Adulthood programs support young people with Duchenne as they transition into independent adults. This category supports those living with Duchenne to lead independent, fulfilling, and rewarding lives. PTC received a total of 46 applications from organizations around the world this year.\nThe 2023 STRIVE Awards recipients are:\nInnovative Category:\nThe Brazil-based Blue Angels (Adapted Sports Association) promotes an improvement in the quality of life of people with disabilities through high performance training in adapted sports. Their vision fosters social inclusion of people with disabilities through adapted sports activities. With the STRIVE grant, Blue Angels will expand its power soccer program, a type of soccer played by people who have any kind of motor limitation and use wheelchairs. The organization will hire professionals to assist with the program, increase the number of players and acquire additional equipment.Transition to Adulthood Category:\nAs patients with Duchenne transition into adulthood and live ind...

More updates from Ptc Therapeutics, Inc.